Promethazine Hydrochloride Suppository
NDC Package 45802-758-30
Package Information
Promethazine Hydrochloride suppositories is promethazine HCl Suppositories are useful for:Perennial and seasonal allergic rhinitis.Vasomotor rhinitis.Allergic conjunctivitis due to inhalant allergens and foods.Mild, uncomplicated allergic skin manifestations of urticaria and angioedema.Amelioration of allergic reactions to blood or plasma.Dermographism.Anaphylactic reactions, as adjunctive therapy to epinephrine and other standard measures, after the acute manifestations have been controlled.Preoperative, postoperative, or obstetric sedation.Prevention and control of nausea and vomiting associated with certain types of anesthesia and surgery.Therapy adjunctive to meperidine or other analgesics for control of postoperative pain.Sedation in both children and adults, as well as relief of apprehension and production of light sleep from which the patient can be easily aroused.Active and prophylactic treatment of motion sickness.Antiemetic therapy in postoperative patients. This formulation utilizes a suppository delivery system. Marketed by Padagis Israel Pharmaceuticals Ltd, this product is identified by NDC 45802-758 and is authorized under FDA application ANDA040500.
Identification & Billing
- RxCUI: 992441 - promethazine HCl 12.5 MG Rectal Suppository
- RxCUI: 992441 - promethazine hydrochloride 12.5 MG Rectal Suppository
- RxCUI: 992454 - promethazine HCl 25 MG Rectal Suppository
- RxCUI: 992454 - promethazine hydrochloride 25 MG Rectal Suppository
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 45802 - Padagis Israel Pharmaceuticals Ltd
- 45802-758 - Promethazine Hydrochloride
- 45802-758-30 - 12 BLISTER PACK in 1 CARTON / 1 SUPPOSITORY in 1 BLISTER PACK (45802-758-00)
- 45802-758 - Promethazine Hydrochloride
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Billing & HCPCS Mapping
To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.
Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 45802-758-30 identifies a specific commercial package of 12 blister pack in 1 carton / 1 suppository in 1 blister pack (45802-758-00) of Promethazine Hydrochloride, a human prescription drug labeled by Padagis Israel Pharmaceuticals Ltd. This suppository is formulated for rectal use and contains promethazine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Padagis Israel Pharmaceuticals Ltd on June 27, 2006. The current certification is valid through December 31, 2026.
How is this Padagis Israel Pharmaceuticals Ltd product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 45802075830. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 12 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.